Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Ikena Oncology, Inc. Financials Banner

Ikena Oncology, Inc. Financials

IKNA Stock Analysis

Page title

Section title

IKNA Income Statement Key Metrics

  • Revenue(TTM)1.84 M
  • Gross Profit(TTM)986,000
  • EBITDA(TTM)-71.58 M
  • Net Income(TTM)-66.71 M
  • EPS Diluted(TTM)-1.42

Decode IKNA's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

IKNA earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of IKNA (0.889) is higher than the average of its peers (0.245).

Net Profit Margin vs Peers

Net profit margin ratio of IKNA (-7.442) is lower than the average of its peers (-5.834).

IKNA Return on Equity

See how efficiently IKNA generates profit for it's shareholders.

-40.16%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of IKNA (-0.402) is lower than the average of its peers (-0.341).

Return on Equity Growth

IKNA's Return on Equity has grown significantly over the past 10 years, increasing by over 12.45%.

IKNA Revenue Growth

See how IKNA has grown it's revenue over the past 10 years.


Revenue Growth

IKNA's revenue has grown significantly over the past 10 years, increasing by over 44.89%.

IKNA FY, 2023 Revenue Breakdown

See how IKNA converts it's revenue into profit.

IKNA Balance Sheet Health

IKNA Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

IKNA financial position analysis

Short Term Liabilities

IKNA's short term assets($179M) can safely cover it's short term liabilities($14M).

Long Term Liabilities

IKNA's short term assets($179M) can safely cover it's long term liabilities($8M).

IKNA Debt to Equity